These in vitro results are consistent with in vivo experimental and human clinical observations that have found autoantibodies against laminin, collagen IV (but not collagen I), B1AR, and CXAR as well as against myosin and actin in RHD and AM (39, 60–62, 78–85). Here, LAMB2 is linked to rheumatic heart disease.